Stage 1: The cancer has grown into the colon wall but has not yet grown outside the colon. If surgery has successfully removed the entire cancerous polyp, no additional treatment may be needed. If, however, some cancer cells remain (if the polyp could not be removed completely), or if ...
OSAKA, Japan and CAMBRIDGE, Massachusetts, November 8, 2023– Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA™ (fruquintinib), an oral targeted therapy for adults with metastatic colorecta...
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment --- YL201 Phase I/II Investigators Meeting was successfully held inGuangzhou, China GUANGZHOU, China,Sept. 23, 2023/PRNewswire/ -- OnSeptember 23...
Cancer, as usual, saw the most approvals in 2023 with 16, including four bispecifics in a span of as many months. Two bispecifics for multiple myeloma—Talvey from Johnson & Johnson and Elrexfio from Pfizer—made the grade. There also were two bispecifics approved for B-cell...
While immunotherapy has given patients more treatment options, it is by no means the one-shot, cure-all for cancer. Using traditional therapies like surgery, chemotherapy, and radiation therapy, in combination with the immunotherapy options described above, will give clinicians the ability to develop...
A new generic treatment for multiple types of cancer一种治疗多种类型癌症的新的通用疗法 souyou 科研新闻,不定期更新!由日本理化学研究所先锋研究集群(CPR)的Katsunori Tanaka和理化学研究所西那加速器科学中心(RNC)的Hiromitsu Haba领导的研究人员已经开发出一种新技术,有可能通用于治疗几种癌症,而且比目前可用...
Insufficient patient enrollment per month (=accrual) is the leading cause of cancer trial termination. To identify and quantify factors associated with pat
Research on a heart medication for childhood cancer survivors and new immunotherapies for blood and solid tumors will be presented. LOS ANGELES, May 26, 2023 /PRNewswire/ -- City of Hope, one of the largest cancer...
Research on a heart medication for childhood cancer survivors and new immunotherapies for blood and solid tumors will be presented. LOS ANGELES, May 26, 2023 /PRNewswire/ --City of Hope, one of the largest cancer research an...
New York Cancer Specialists is delivering state-of-the-art medical technology and world-class cancer care to all of our New York communities